In reply: Neuromuscular monitoring should be required when neuromuscular blocking drugs are used: Is it time to change the Canadian guidelines?

被引:4
作者
Dobson, Gregory [1 ]
Merchant, Richard N. [1 ]
机构
[1] Canadian Anesthesiologists Soc, Stand Comm, Toronto, ON, Canada
来源
CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE | 2016年 / 63卷 / 07期
关键词
Cholinesterase; Meaningful Change; Peripheral Nerve Stimulator; Reversal Agent; Canadian Guideline;
D O I
10.1007/s12630-016-0640-z
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
引用
收藏
页码:892 / 893
页数:2
相关论文
共 5 条
[1]   Residual Neuromuscular Block: Lessons Unlearned. Part II: Methods to Reduce the Risk of Residual Weakness [J].
Brull, Sorin J. ;
Murphy, Glenn S. .
ANESTHESIA AND ANALGESIA, 2010, 111 (01) :129-140
[2]   Neuromuscular monitoring should be required when neuromuscular blocking drugs are used: Is it time to change the Canadian guidelines? [J].
Hudson, Robert J. .
CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2016, 63 (07) :891-891
[3]   Managing Neuromuscular Block: Where Are the Guidelines? [J].
Kopman, Aaron F. .
ANESTHESIA AND ANALGESIA, 2010, 111 (01) :9-10
[4]   Guidelines to the Practice of Anesthesia - Revised Edition 2016 [J].
Merchant, Richard ;
Chartrand, Daniel ;
Dain, Steven ;
Dobson, Gregory ;
Kurrek, Matt M. ;
Lagace, Annie ;
Stacey, Shean ;
Thiessen, Barton ;
Chow, Lorraine ;
Sullivan, Patrick .
CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2016, 63 (01) :89-112
[5]  
Stoelting RK, 2015, ASA NEWSLETTER, V79, P2